Mal-C2-amide-C10-tri-GalNAc is an asialoglycoprotein receptor ( ASGPR ) binding ligand fragment and a component of lysosome-targeted bifunctional molecules. Mal-C2-amide-C10-tri-GalNAc is used in the research of autoimmune diseases [1].
In Vitro, Mal-C2-amide-C10-tri-GalNAc (Compound 1226) can facilitate the isolation and degradation of extracellular target molecules in lysosomes[1].
References:
[1]. Darrin Anthony Lindhout, et al. Lysosomal targeting bifunctional molecules for degradation of autoantibodies. WO2024155750A1. 2025-07-18.
In Vitro, Mal-C2-amide-C10-tri-GalNAc (Compound 1226) can facilitate the isolation and degradation of extracellular target molecules in lysosomes[1].
References:
[1]. Darrin Anthony Lindhout, et al. Lysosomal targeting bifunctional molecules for degradation of autoantibodies. WO2024155750A1. 2025-07-18.